Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H20N6.2C4H4O4 |
Molecular Weight | 552.5359 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)\C=C/C(O)=O.OC(=O)\C=C/C(O)=O.C(N1CCN(CC1)C2=NC=CC=N2)C3=CN=C(N3)C4=CC=CC=C4
InChI
InChIKey=CEFBXMNJODPQHJ-SPIKMXEPSA-N
InChI=1S/C18H20N6.2C4H4O4/c1-2-5-15(6-3-1)17-21-13-16(22-17)14-23-9-11-24(12-10-23)18-19-7-4-8-20-18;2*5-3(6)1-2-4(7)8/h1-8,13H,9-12,14H2,(H,21,22);2*1-2H,(H,5,6)(H,7,8)/b;2*2-1-
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/9327946Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/9016321 | https://www.google.com/patents/WO1996010018A1 | https://www.ncbi.nlm.nih.gov/pubmed/9262370
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9327946
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/9016321 | https://www.google.com/patents/WO1996010018A1 | https://www.ncbi.nlm.nih.gov/pubmed/9262370
NGD 94-1 is high affinity D4 receptor ligand, shows selective over D1, D2, D3 and D5 receptors. Displays antagonist activity at the human D4.2 receptor (Ki = 3.6 nM in transfected CHO cells) and exhibits agonist activity at the D4.4 receptor in HEK 293 cells.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL219 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9016321 |
3.8 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10102786
In drug reversal studies NGD94-1 was administered at 1 or 5 mg/kg intramuscularly 45 min prior to testing. Haloperidol was given at 0.025 mg/kg intramuscularly 30 min prior to testing
Route of Administration:
Intramuscular
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9262370
The dopamine D4 receptor is a Gprotein-coupled receptor and is negatively linked to adenylate cyclase, so that agonists at D4 receptors will inhibit forskolin-stimulated cAMP production. CHO cells stably expressing the cloned human D4.2 receptor were plated in 24-well plates 1 to 2 days before the assay, and were grown to confluence in Ham’s media with 10% FBS. On the day of the assay, each well was washed three times with serum-free Ham’s media containing 0.1 M HEPES. After a 30-min preincubation with NGD 94-1 and 50 mkM IBMX (phosphodiesterase inhibitor) at 37°C, cells were incubated with 5 mM forskolin for 15 min at 37°C. To stop the reaction, the plates were washed three times with cold PBS. Each well was incubated with 0.1 mM HCl for 20 min at room temperature. An aliquot of each sample was transferred to 12 * 75 mm polypropylene tubes, and the acid was neutralized with the addition of a solution containing 0.1 mM HEPES-0.1 mM K2CO3. The remaining acid was removed from the plates, and the cells were lysed with 0.5% Triton X-100. The protein content of each well was then determined with the Bio-Rad protein assay (Hercules, CA). The cAMP content in the neutralized extracts was determined with a cAMP RIA kit (NEN-DuPont, Boston, MA). The samples were quantitated using a gamma counter with an efficiency of 80 to 85%
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
7E1IX9C8PJ
Created by
admin on Sat Dec 16 05:09:08 GMT 2023 , Edited by admin on Sat Dec 16 05:09:08 GMT 2023
|
PRIMARY | |||
|
9893821
Created by
admin on Sat Dec 16 05:09:08 GMT 2023 , Edited by admin on Sat Dec 16 05:09:08 GMT 2023
|
PRIMARY | |||
|
179333-18-7
Created by
admin on Sat Dec 16 05:09:08 GMT 2023 , Edited by admin on Sat Dec 16 05:09:08 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
PARENT (SALT/SOLVATE)